Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways
0 Tampilan
• 07/04/23
0
0
Menanamkan
administrator
Pelanggan
Earn CME for related activities: https://www.naccme.com/oln
This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.
© 2018 NACCME, an HMP Company
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru